« go back

Antibody Drug Conjugates: Innovation in Design, Development and Manufacture

Antibody Drug Conjugates: Innovation in Design, Development and Manufacture

Wednesday 26th  June, 2013

Barry Cross Conference Centre, Cambridge


The HealthTech and Medicines KTN (Health KTN) is pleased to invite you to attend this meeting on Antibody Drug Conjugates (ADCs) in Cambridge on Wednesday, 26th June 2013.  This event is being held at the Barry Cross Conference Centre, Babraham Research Campus in Cambridge.


With a focus on innovation in ADC design, development and manufacture, the meeting will be of interest to those working in all aspects of these areas from academic groups, spin outs, SMEs, CMOs and large pharma. One aim of this event is to identify and build a UK-focussed ADC community of industrialists and academics working in this global ADC arena. This will be a KTN-facilitated forum for knowledge transfer and dissemination of best practice in this field, support for collaborations, and highlighting TSB funding opportunities of relevance. Alongside the technical presentations, the event will provide delegates the opportunity to network with peers in industry and academia and meet new contacts through dedicated speed networking sessions.

The agenda will include presentations from organisations with cutting edge ideas on the design and manufacture of next generation of ADC technology. The final agenda will be available soon with confirmed representation from: ADC Biotechnology, Almac, Polytherics, Spirogen.

About the Health KTN

The Health KTN is dedicated to accelerating innovation and technology exploitation in the health industries sector. This includes the medical biotechnology, medical technology, diagnostics and pharmaceutical industries. The KTN is funded by the Technology Strategy Board, the UK’s national innovation agency and can help you connect with other organisations to catalyse innovation. This could include companies, the science and clinical base and the public sector from both within and outwith your sector. The KTN does this through running events and workshops for practitioners and innovation leaders in its priority areas and creates awareness of funding vehicles at the public-private sector interface.

The main aims of this event are:

·        to identify and build a UK-focussed ADC community of industrialists and academics working in this global ADC arena

·        present the latest data on hot topics in this field

·        provide a forum for networking


The main beneficiaries will be:

·        Practitioners in the ADC arena and technical specialists from a range of organisations such as academic groups, spin outs and SMEs, CMOs and large pharma

·        Technical specialists from areas such as ADC therapeutic design, development, manufacture, regulation, enabling technologies

Event location and time

Wednesday 26th June. 09.30 – 16.30

Barry Cross Conference Centre

Babraham Research Campus



CB22 3AT

Location map available – click here


Registration details

This event is free to attend however places are limited and you are advised to register your interest as soon as possible.

To register click here

These events are often heavily oversubscribed, so don’t miss out! Please be aware that in the event of over subscription, and to ensure the emphasis remains on technical networking, preference will be given to delegates who are practitioners in this field, and we may have to restrict the number of delegates per organisation.



With any programme enquiries, please contact:

For any logistics questions, please contact:



No comments yet. Be the first.


Most read articles

Report published on Assessment of the UK Biopharmaceutical Portfolio Value

As part of bioProcessUK’s annual activity on sector information, Unicorn Biologics...

TSB funding call Technology-Inspired Collaborative R+D High Value Manufacturing

The HealthTech and Medicines KTN wanted you to be aware of the latest announcement from the ...

8th Annual bioProcessUK Conference 2011 - Venue Confirmed!

The HealthTech and Medicines KTN is delighted to announce the launch of the 8th Annual...